Highbridge Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-300,000
Closed -$5.26M 551
2018
Q1
$5.26M Buy
300,000
+100,000
+50% +$1.75M 0.08% 211
2017
Q4
$4.93M Buy
200,000
+100,000
+100% +$2.47M 0.09% 227
2017
Q3
$2.58M Buy
+100,000
New +$2.58M 0.04% 325
2017
Q1
Sell
-13,105
Closed -$355K 1054
2016
Q4
$355K Buy
+13,105
New +$355K 0.01% 737